Burdening Perspectives and Treatment Modalities of Monkeypox: A Central Dogma


Cite item

Full Text

Abstract

The monkeypox virus (MPXV), belonging to the genus Orthopoxvirus, is responsible for causing the zoonotic illness known as Monkeypox. The virus was initially identified during an outbreak at a Danish Zoo in 1958 and has since been found to infect various mammal species worldwide. While African squirrels and other rodents are believed to be the primary hosts, determining the natural host has proven challenging. While MPXV can be studied using different animal models in laboratory settings, understanding its natural transmission routes remains complex and species-dependent. Recent developments have elevated the global health concern surrounding Monkeypox, leading to its designation as a Global Health Emergency of International Concern on 23 July 2022. Enhancing surveillance and case detection is crucial in navigating the unpredictable epidemiology of this re-emerging disease. Human infections with the monkeypox virus are becoming less frequent due to population growth and economic improvements. Monkeypox, similar to smallpox, can potentially be controlled and eradicated in the future through vaccines, appropriate treatment, and personal protective equipment.

About the authors

Shivang Dhoundiyal

Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University

Email: info@benthamscience.net

Md. Alam

Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University

Author for correspondence.
Email: info@benthamscience.net

Awaneet Kaur

Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University

Email: info@benthamscience.net

Sandesh Varshney

Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University

Email: info@benthamscience.net

References

  1. Barrett J, McFadden G. Origin and Evolution of Poxviruses. Sciencedirect 2008; pp. 431-46. doi: 10.1016/B978-0-12-374153-0.00019-9
  2. Diven DG. An overview of poxviruses. J Am Acad Dermatol 2001; 44(1): 1-16. doi: 10.1067/mjd.2001.109302 PMID: 11148468
  3. Odom MR, Curtis Hendrickson R, Lefkowitz EJ. Poxvirus protein evolution: Family wide assessment of possible horizontal gene transfer events. Virus Res 2009; 144(1-2): 233-49. doi: 10.1016/j.virusres.2009.05.006 PMID: 19464330
  4. Lefkowitz EJ, Wang C, Upton C. Poxviruses: Past, present and future. Virus Res 2006; 117(1): 105-18. doi: 10.1016/j.virusres.2006.01.016 PMID: 16503070
  5. Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A pox-like disease in cynomolgus monkeys. Acta Pathol Microbiol Scand 1959; 46(2): 156-76. doi: 10.1111/j.1699-0463.1959.tb00328.x
  6. Arita I, Henderson DA. Smallpox and monkeypox in non-human primates Available from: https://apps.who.int/iris/bitstream/handle/10665/266595/PMC2554549.pdf?sequence=1 (Accessed on: Sep 8, 2022).
  7. Khodakevich L, Ježek Z, Messinger D. Monkeypox virus: Ecology and public health significance. Bull World Health Organ 1988; 66(6): 747-52.
  8. Moore M, Zahra F. Monkeypox. In: Stat Pearls. Treasure Island, FL: Stat Pearls Publishing 2022.
  9. Georges AJ, Matton T, Courbot-Georges MC. Monkey-pox, an emerging then re-emerging disease paradigm. Med Mal Infect 2004; 34(1): 12-9. doi: 10.1016/j.medmal.2003.09.008 PMID: 15617321
  10. Eradication W, Organization W. The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication. Geneva: World Health Organization 1979.
  11. Smallpox.. Available from: https://www.who.int/health-topics/smallpox#tab=tab_1 (Accessed on: Sep 7, 2022).
  12. Wenner HA, Kamitsuka P, Macasaet F, Kidd P. Pathogenesis of monkey pox. Antimicrob Agents Chemother 1967; 7: 40-4. PMID: 4299355
  13. Wenner HA, Macasaet FD, Kamitsuka PS, Kidd P. Monkey pox. I. Clinical, virologic and immunologic studies. Am J Epidemiol 1968; 87(3): 551-66. doi: 10.1093/oxfordjournals.aje.a120846 PMID: 4297615
  14. Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution. Viruses 2020; 12(11): 1257. doi: 10.3390/v12111257 PMID: 33167496
  15. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972; 46(5): 593-7. PMID: 4340218
  16. Gispen R, Brand-Saathof BB, Hekker AC. Monkeypox-specific antibodies in human and simian sera from the Ivory Coast and Nigeria. Bull World Health Organ 1976; 53(4): 355-60. PMID: 186210
  17. Yinka-Ogunleye A, Aruna O, Dalhat M, et al. Outbreak of human monkeypox in Nigeria in 2017–18: A clinical and epidemiological report. Lancet Infect Dis 2019; 19(8): 872-9. doi: 10.1016/S1473-3099(19)30294-4 PMID: 31285143
  18. Pastula DM, Tyler KL. An overview of monkeypox virus and its neuroinvasive potential. Ann Neurol 2022; 92(4): 527-31. doi: 10.1002/ana.26473 PMID: 35932225
  19. Saadh MJ, Ghadimkhani T, Soltani N, et al. Progress and prospects on vaccine development against monkeypox infection. Microb Pathog 2023; 180: 106156. doi: 10.1016/j.micpath.2023.106156 PMID: 37201635
  20. Angelo KM, Petersen BW, Hamer DH, Schwartz E, Brunette G. Monkeypox transmission among international travellers—serious monkey business? J Travel Med 2019; 26(5): taz002. doi: 10.1093/jtm/taz002 PMID: 30657959
  21. Weinstein RA, Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: Prevalence, diagnostics, and countermeasures. Clin Infect Dis 2005; 41(12): 1765-71. doi: 10.1086/498155 PMID: 16288402
  22. Reynolds MG, Yorita KL, Kuehnert MJ, et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 2006; 194(6): 773-80. doi: 10.1086/505880 PMID: 16941343
  23. Sejvar JJ, Chowdary Y, Schomogyi M, et al. Human monkeypox infection: A family cluster in the midwestern United States. J Infect Dis 2004; 190(10): 1833-40. doi: 10.1086/425039 PMID: 15499541
  24. Fleischauer AT, Kile JC, Davidson M, et al. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers. Clin Infect Dis 2005; 40(5): 689-94. doi: 10.1086/427805 PMID: 15714414
  25. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004; 350(4): 342-50. doi: 10.1056/NEJMoa032299 PMID: 14736926
  26. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries — april–June 2022. N Engl J Med 2022; 387(8): 679-91. doi: 10.1056/NEJMoa2207323 PMID: 35866746
  27. O’Toole A, Rambaut A. Initial observations about putative APOBEC3 deaminase editing driving short-term evolution of MPXV since 2017. Virol J 2022; 30.
  28. Jezek Z, Marennikova SS, Mutumbo M, Nakano JH, Paluku KM, Szczeniowski M. Human monkeypox: A study of 2,510 contacts of 214 patients. J Infect Dis 1986; 154(4): 551-5. doi: 10.1093/infdis/154.4.551 PMID: 3018091
  29. Formenty P, Muntasir MO, Damon I, et al. Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005. Emerg Infect Dis 2010; 16(10): 1539-45. doi: 10.3201/eid1610.100713 PMID: 20875278
  30. Faye O, Pratt CB, Faye M, et al. Genomic characterisation of human monkeypox virus in Nigeria. Lancet Infect Dis 2018; 18(3): 246. doi: 10.1016/S1473-3099(18)30043-4 PMID: 29361427
  31. Baker RO, Bray M, Huggins JW. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res 2003; 57(1-2): 13-23. doi: 10.1016/S0166-3542(02)00196-1 PMID: 12615299
  32. Mukinda VBK, Mwema G, Kilundu M, Heymann DL, Khan AS, Esposito JJ. Re-emergence of human monkeypox in Zaire in 1996. Lancet 1997; 349(9063): 1449-50. doi: 10.1016/S0140-6736(05)63725-7 PMID: 9164323
  33. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis 2019; 13(10): e0007791. doi: 10.1371/journal.pntd.0007791 PMID: 31618206
  34. Yadav PD, Reghukumar A, Sahay RR, et al. First two cases of Monkeypox virus infection in travellers returned from UAE to India, July 2022. J Infect 2022; 85(5): e145-8. doi: 10.1016/j.jinf.2022.08.007 PMID: 35963550
  35. Chen N, Li G, Liszewski MK, et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005; 340(1): 46-63. doi: 10.1016/j.virol.2005.05.030 PMID: 16023693
  36. Wang L, Shang J, Weng S, et al. Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022. J Med Virol 2023; 95(1): e28036. doi: 10.1002/jmv.28036 PMID: 35906185
  37. Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: Monkeypox viruses. J Gen Virol 2005; 86(10): 2661-72. doi: 10.1099/vir.0.81215-0 PMID: 16186219
  38. Parker S, Chen NG, Foster S, et al. Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox – An animal model of smallpox. Antiviral Res 2012; 94(1): 44-53. doi: 10.1016/j.antiviral.2012.02.005 PMID: 22381921
  39. Americo JL, Moss B, Earl PL. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. J Virol 2010; 84(16): 8172-80. doi: 10.1128/JVI.00621-10 PMID: 20519404
  40. Esposito J, Fenner F. Poxvirus. In: Fields Virology. LWW 2001; pp. 2885-921.
  41. Sadeuh-Mba SA, Bessaud M, Massenet D, et al. High frequency and diversity of species C enteroviruses in Cameroon and neighboring countries. J Clin Microbiol 2013; 51(3): 759-70. doi: 10.1128/JCM.02119-12 PMID: 23254123
  42. Lum FM, Torres-Ruesta A, Tay MZ, et al. Monkeypox: Disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol 2022; 22(10): 597-613. doi: 10.1038/s41577-022-00775-4 PMID: 36064780
  43. Gomez-Lucia E. Monkeypox: Some keys to understand this emerging disease. Animals 2022; 12(17): 2190. doi: 10.3390/ani12172190 PMID: 36077910
  44. Cho CT, Wenner HA. Monkeypox virus. Bacteriol Rev 1973; 37(1): 1-18. doi: 10.1128/br.37.1.1-18.1973 PMID: 4349404
  45. Andiman WA. Animals Viruses and Humans, a Narrow Divide: How Lethal Zoonotic Viruses Spill Over and Threaten us. Paul Dry Books 2018.
  46. World Health Assembly Proclaims Global Smallpox Eradication. Environ 1980; 7(3): 173-4.
  47. Arita I, Jezek Z, Ruti K, Khodakevich L. Human monkeypox: A newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am J Trop Med Hyg 1985; 34(4): 781-9. doi: 10.4269/ajtmh.1985.34.781 PMID: 2992305
  48. Grant R, Nguyen LBL, Breban R. Modelling human-to-human transmission of monkeypox. Bull World Health Organ 2020; 98(9): 638-40. doi: 10.2471/BLT.19.242347 PMID: 33012864
  49. Monkeypox.. Available from: https://www.who.int/news-room/fact-sheets/detail/monkeypox (Accessed on: Sep 7, 2022).
  50. Dubey A, Singh R, Kumar A, et al. A critical review on changing epidemiology of human monkeypox-a current threat with multi-country outbreak. J Pharm Negat Results 2022; 13(S01): 660-71. doi: 10.47750/pnr.2022.13.S01.82
  51. Jordens Q, De Maeseneer H, De Crem C, Fölster-Holst R, Van Gysel D. Acral manifestations associated with infection. Pediatr Dermatol 2021; 38(6): 1475-87. doi: 10.1111/pde.14831 PMID: 34713504
  52. Sookaromdee P, Wiwanitkit V. Mouth sores and monkeypox: A consideration. J Stomatol Oral Maxillofac Surg 2022; 123(6): 593-4. doi: 10.1016/j.jormas.2022.06.020 PMID: 35760308
  53. Roy R, Nirala S, Pandey S, Singh CM. A review of india in the midst of another epidemic with monkeypox. Asian J Res Infect Dis 2022; 10(4): 15-21. doi: 10.9734/ajrid/2022/v10i430296
  54. Ahmed SK, El-Kader RGA, Abdulqadir SO, et al. Monkeypox clinical symptoms, pathology, and advances in management and treatment options: An update. Int J Surg 2023; 10-97. doi: 10.1097/JS9.0000000000000091 PMID: 36906774
  55. Tiecco G, Degli Antoni M, Storti S, Tomasoni LR, Castelli F, Quiros-Roldan E. Monkeypox, a literature review: What is new and where does this concerning virus come from? Viruses 2022; 14(9): 1894. doi: 10.3390/v14091894 PMID: 36146705
  56. Hutson CL, Kondas AV, Mauldin MR, et al. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. MSphere 2021; 6(1): e00927-20. doi: 10.1128/mSphere.00927-20 PMID: 33536322
  57. Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Correction to: Prevention and treatment of monkeypox. Drugs 2022; 82(12): 1343. doi: 10.1007/s40265-022-01767-3 PMID: 35994201
  58. Antinori A, Mazzotta V, Vita S, et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill 2022; 27(22): 2200421. doi: 10.2807/1560-7917.ES.2022.27.22.2200421 PMID: 35656836
  59. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed: Interim guidance, 12 July 2021. World Health Organization. 2021.
  60. Ogoina D, Izibewule JH, Ogunleye A, et al. The 2017 human monkeypox outbreak in Nigeria-Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria. PLoS One 2019; 14(4): e0214229. doi: 10.1371/journal.pone.0214229 PMID: 30995249
  61. Yuan P, Tan Y, Yang L, et al. Assessing transmission risks and control strategy for monkeypox as an emerging zoonosis in a metropolitan area. J Med Virol 2023; 95(1): e28137. doi: 10.1002/jmv.28137 PMID: 36089815
  62. Hasan S, Saeed S. Monkeypox disease: An emerging public health concern in the shadow of COVID-19 pandemic: An update. Trop Med Infect Dis 2022; 7(10): 283. doi: 10.3390/tropicalmed7100283 PMID: 36288024
  63. Strathdee SA, Crago AL, Shannon K. Harm reduction and rights-based approaches to reduce monkeypox transmission among sex workers. Lancet Infect Dis 2023; 23(1): e43-6. doi: 10.1016/S1473-3099(22)00661-2 PMID: 36243028
  64. Daskalakis D, McClung RP, Mena L, et al. Monkeypox: Avoiding the mistakes of past infectious disease epidemics. Ann Intern Med 2022; 175(8): 1177-8. doi: 10.7326/M22-1748 PMID: 35709341
  65. Islam MM, Dutta P, Rashid R, et al. Pathogenicity and virulence of monkeypox at the human-animal-ecology interface. Virulence 2023; 14(1): 2186357. doi: 10.1080/21505594.2023.2186357 PMID: 36864002
  66. Jiang RM, Zheng YJ, Zhou L, et al. Diagnosis, treatment, and prevention of monkeypox in children: An experts’ consensus statement. World J Pediatr 2023; 19(3): 231-42. doi: 10.1007/s12519-022-00624-3 PMID: 36409451
  67. Bergman A, McGee K, Farley J, Kwong J, McNabb K, Voss J. Combating stigma in the era of monkeypox—is history repeating itself? J Assoc Nurses AIDS Care 2022; 33(6): 668-75. doi: 10.1097/JNC.0000000000000367 PMID: 36198116
  68. Bauer DJ, Vincent LS, Kempe CH, Downie AW. PRophylactic treatment of smallpox contacts with n-methylisatin β-thiosemicarbazone (compound 33T57, MARBORAN). Lancet 1963; 282(7306): 494-6. doi: 10.1016/S0140-6736(63)90230-7 PMID: 14065422
  69. Cho CT, Bolano CR, Kamitsuka PS, Wenner HA. Methisazone and monkey pox virus: Studies in cell cultures, chick embryos, mice and monkeys. Am J Epidemiol 1970; 92(2): 137-44. doi: 10.1093/oxfordjournals.aje.a121186 PMID: 4317162
  70. Di Gennaro F, Veronese N, Marotta C, et al. Human monkeypox: A comprehensive narrative review and analysis of the public health implications. Microorganisms 2022; 10(8): 1633. doi: 10.3390/microorganisms10081633 PMID: 36014051
  71. Chakraborty S, Chandran D, Mohapatra RK, et al. Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects. Int J Surg 2022; 105: 106847. doi: 10.1016/j.ijsu.2022.106847 PMID: 35995352
  72. Joklik WK. The poxviruses. Bacteriol Rev 1966; 30(1): 33-66. doi: 10.1128/br.30.1.33-66.1966 PMID: 5324648
  73. Pirrung MC, Pansare SV, Sarma KD, Keith KA, Kern ER. Combinatorial optimization of isatin-β-thiosemicarbazones as anti-poxvirus agents. J Med Chem 2005; 48(8): 3045-50. doi: 10.1021/jm049147h PMID: 15828843
  74. Wang J, Shahed-AI-Mahmud M, Chen A, Li K, Tan H, Joyce R. An overview of antivirals against monkeypox virus and other orthopoxviruses. J Med Chem 2023; 66(7): 4468-90. doi: 10.1021/acs.jmedchem.3c00069 PMID: 36961984
  75. Almehmadi M, Allahyani M, Alsaiari AA, et al. A glance at the development and patent literature of tecovirimat: The first-in-class therapy for emerging monkeypox outbreak. Viruses 2022; 14(9): 1870. doi: 10.3390/v14091870 PMID: 36146675
  76. Siegrist E, Sassine J. Antivirals with activity against monkeypox: A clinically oriented review. Clin Infect Dis 2022; 76(1): 155-64. doi: 10.1093/cid/ciac622 PMID: 35904001
  77. Chan-Tack K, Harrington P, Bensman T, et al. Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration’s Evaluation. Antiviral Res 2021; 195: 105182. doi: 10.1016/j.antiviral.2021.105182 PMID: 34582915
  78. Ajmal A, Mahmood A, Hayat C, et al. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Front Cell Infect Microbiol 2023; 13: 1159389. doi: 10.3389/fcimb.2023.1159389 PMID: 37313340
  79. Hu X, An S, Chu J, et al. Potential inhibitors of monkeypox virus revealed by molecular modeling approach to viral DNA topoisomerase I. Molecules 2023; 28(3): 1444. doi: 10.3390/molecules28031444 PMID: 36771105
  80. Bowie JU, Lüthy R, Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science 1991; 253(5016): 164-70. doi: 10.1126/science.1853201 PMID: 1853201
  81. Sk MF, Roy R, Jonniya NA, Poddar S, Kar P. Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. J Biomol Struct Dyn 2021; 39(10): 3649-61. doi: 10.1080/07391102.2020.1768149 PMID: 32396767
  82. Sahoo AK, Augusthian PD, Muralitharan I, et al. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs. Mol Divers 2022; 1-16. doi: 10.1007/s11030-022-10550-1 PMID: 36331784
  83. Li D, Liu Y, Li K, Zhang L. Targeting F13 from monkeypox virus and variola virus by tecovirimat: Molecular simulation analysis. J Infect 2022; 85(4): e99-e101. doi: 10.1016/j.jinf.2022.07.001 PMID: 35810941
  84. Patel M, Bazaid AS, Azhar EI, et al. Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine/threonine kinase: integrating computational modeling and molecular dynamics simulation. J Biomol Struct Dyn 2023; 1-17. doi: 10.1080/07391102.2023.2179547 PMID: 36852556
  85. Amir M, Mohammad T, Prasad K, et al. Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1). J Biomol Struct Dyn 2020; 38(15): 4625-34. doi: 10.1080/07391102.2019.1682052 PMID: 31625455
  86. Bekker H, Berendsen HJ, Dijkstra EJ, et al. Gromacs-a parallel computer for molecular-dynamics simulations. In4th international conference on computational physics (PC 92). 252-6.
  87. Kelvin AA, Halperin S. COVID-19 in children: The link in the transmission chain. Lancet Infect Dis 2020; 20(6): 633-4. doi: 10.1016/S1473-3099(20)30236-X PMID: 32220651
  88. Shiryaev VA, Skomorohov MY, Leonova MV, et al. Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity. Eur J Med Chem 2021; 221: 113485. doi: 10.1016/j.ejmech.2021.113485 PMID: 33965861
  89. Yang G, Pevear DC, Davies MH, et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J Virol 2005; 79(20): 13139-49. doi: 10.1128/JVI.79.20.13139-13149.2005 PMID: 16189015
  90. Bryk P, Brewer MG, Ward BM. Vaccinia virus phospholipase protein F13 promotes rapid entry of extracellular virions into cells. J Virol 2018; 92(11): e02154-17. doi: 10.1128/JVI.02154-17 PMID: 29540596
  91. Rabaan AA, Abas AH, Tallei TE, et al. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies. J Med Virol 2023; 95(1): e28306. doi: 10.1002/jmv.28306 PMID: 36372558
  92. Ali Y, Imtiaz H, Tahir MM, et al. Fragment-based approaches identified tecovirimat-competitive novel drug candidate for targeting the F13 protein of the monkeypox virus. Viruses 2023; 15(2): 570. doi: 10.3390/v15020570 PMID: 36851785
  93. Brown K, Leggat P. Human Monkeypox: Current state of knowledge and implications for the future. Trop Med Infect Dis 2016; 1(1): 8. doi: 10.3390/tropicalmed1010008 PMID: 30270859
  94. Petersen E, Abubakar I, Ihekweazu C, et al. Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis 2019; 78: 78-84. doi: 10.1016/j.ijid.2018.11.008 PMID: 30453097
  95. Hutson CL, Carroll DS, Gallardo-Romero N, et al. Comparison of monkeypox virus clade kinetics and pathology within the prairie dog animal model using a serial sacrifice study design. BioMed Res Int 2015; 2015: 1-19. doi: 10.1155/2015/965710 PMID: 26380309
  96. Mucker EM, Chapman J, Huzella LM, et al. Susceptibility of marmosets (callithrix jacchus) to monkeypox virus: A low dose prospective model for monkeypox and smallpox disease. PLoS One 2015; 10(7): e0131742. doi: 10.1371/journal.pone.0131742 PMID: 26147658
  97. Rimoin AW, Graham BS. Whither monkeypox vaccination. Vaccine 2011; 29(S4): D60-4. doi: 10.1016/j.vaccine.2011.09.004 PMID: 22188935
  98. Belongia E, Naleway A. Smallpox vaccine: The good, the bad, and the ugly. Clin Med Res 2003; 1(1): 87-92. doi: 10.3121/cmr.1.2.87
  99. Heraud JM, Edghill-Smith Y, Ayala V, et al. Subunit recombinant vaccine protects against monkeypox. J Immunol 2006; 177(4): 2552-64. doi: 10.4049/jimmunol.177.4.2552 PMID: 16888017
  100. Petersen B, Damon I, Pertowski C, Delman-Meaney D, Guarnizo J. Clinical guidance for smallpox vaccine use in a postevent vaccination program.In: Morbidity and Mortality Weekly Report: Recommendations and Reports. 2015; 64: pp. (2)1-26.
  101. Kenner J, Cameron F, Empig C, Jobes DV, Gurwith M. LC16m8: An attenuated smallpox vaccine. Vaccine 2006; 24(47-48): 7009-22. doi: 10.1016/j.vaccine.2006.03.087 PMID: 17052815

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers